Ulta Beauty Sales Up 10% as GLP-1 Craze Fuels Hair and Skin Product Demand
Ulta Beauty CEO Kecia Steelman said GLP-1 weight-loss drugs like Wegovy and Foundayo could boost demand for hair loss and skin elasticity products. Ulta posted record 2025 sales of $12.4 billion, up 10% with comparable sales +5.4%, launched over 100 brands and saw shares rise 51% in last year.
1. CEO Highlights GLP-1 Opportunity
Ulta Beauty CEO Kecia Steelman said the growing use of GLP-1 weight-loss drugs such as Wegovy and Foundayo is creating new beauty care needs, particularly for products that address hair thinning and rapid skin elasticity changes following weight loss.
2. Record Financial Results
In fiscal 2025 Ulta Beauty delivered record sales of $12.4 billion, marking a 10% increase year-over-year and a 5.4% rise in comparable sales, driven by higher foot traffic and increased average transaction values.
3. Brand Launches and Strategic Initiatives
The company introduced over 100 new brands including Moroccan Oil and Cécred under its “Ulta Beauty Unleashed” strategy, enhancing product assortment and supporting strong customer engagement across stores and online channels.
4. Market Response and Future Outlook
Shares have climbed 51% in the past year, outperforming the S&P 500, and analysts expect continued growth as Target closes its Ulta Beauty shops, while management focuses on SG&A optimization to bolster operating margins.